Cyclo Therapeutics, Inc. (CYTH)
NASDAQ: CYTH · IEX Real-Time Price · USD
1.210
+0.010 (0.83%)
At close: Jul 19, 2024, 4:00 PM
1.300
+0.090 (7.44%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Cyclo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 1996
Market Capitalization
3536122417-
Upgrade
Market Cap Growth
350.14%200.10%-49.98%38.39%--
Upgrade
Enterprise Value
32281185-3
Upgrade
PE Ratio
--1.80-0.78-1.68-1.95-
Upgrade
PS Ratio
30.7433.588.7615.1819.26-
Upgrade
PB Ratio
56.767.6016.401.541.67-
Upgrade
P/FCF Ratio
-2.22-2.23-0.80-1.60-2.02-
Upgrade
P/OCF Ratio
-2.22-2.23-0.80-1.60-2.04-
Upgrade
EV/Sales Ratio
28.6725.957.634.795.21-2.75
Upgrade
EV/EBITDA Ratio
-1.94-1.39-0.68-0.53-0.530.37
Upgrade
EV/EBIT Ratio
-1.94-1.39-0.68-0.53-0.530.37
Upgrade
EV/FCF Ratio
-2.09-1.73-0.69-0.51-0.550.42
Upgrade
Debt / Equity Ratio
1.090.22-0.010.020.06
Upgrade
Debt / EBITDA Ratio
-0.03-0.05--0.01-0.02-0.01
Upgrade
Debt / FCF Ratio
-0.04-0.06--0.01-0.02-0.01
Upgrade
Quick Ratio
0.471.110.464.483.530.94
Upgrade
Current Ratio
1.001.461.205.073.831.26
Upgrade
Asset Turnover
0.150.160.140.100.160.21
Upgrade
Return on Equity (ROE)
-2741.60%-4505.70%-212.10%-117.20%-566.80%-355.40%
Upgrade
Return on Assets (ROA)
-253.10%-290.80%-152.70%-90.70%-156.40%-154.70%
Upgrade
Return on Capital (ROIC)
-1581.39%-346.28%-2126.75%-90.20%-84.17%-763.24%
Upgrade
Earnings Yield
-56.01%-55.49%-128.28%-59.33%-51.39%-
Upgrade
FCF Yield
-51.99%-44.79%-125.61%-62.41%-49.39%-
Upgrade
Buyback Yield / Dilution
-159.78%-93.50%-32.48%-298.32%-47.81%-32.33%
Upgrade
Total Shareholder Return
-159.78%-93.50%-32.48%-298.32%-47.81%-32.33%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).